Non-Opioid Pain Relief Market to Hit $10.3 Billion

Non-Opioid Pain Relief Market to Hit $10.3 Billion in 2031


Non-Opioid Pain Relief Device Market to Reach a Revenue of US$ 10,311 Million By 2031 | Astute Analytica
OCTOBER 12TH, 2023

The global Non Opioid Pain Relief Device Market is forecast to grow at a CAGR of 8.3% during the forecast period from 2023 to 2031. The global market is forecast to increase in revenue of reach US$ 10,311 million by 2031 from US$ 5,031 million in 2022.

The global non-opioid pain management devices market is witnessing significant growth possibilities during the forecast period. The aging global population that experiences chronic pain and the rising need for non-invasive, non-pharmacological pain management solutions are the major factors driving the market growth. Asia Pacific is predicted to become a rapidly expanding market owing to its sizable population, rising healthcare spending, and rising use of cutting-edge medical technology. The market future is promising with technological advancements focusing on intelligent, connected devices that offer tailored pain management.

https://www.medgadget.com/2023/10/non-opioid-...ytica.html

List of Prominent Players
Abbott Laboratories
Bayer AG
Bioelectronics Corporation (BIEL paid to have a link to their website)
Boston Scientific Corporation
Medtronic plc
Koninklijke Philips N.V.
Neurometrix Inc.
Nuvectra Corporation
Omron Corporation
Stryker Corporation
SPR Therapeutics, LLC
Stimwave LLC
Thermotek Inc.
Zynex Medical
Other Prominent Players